Investing in the age of Longevity: Science panel

The Longevity Week: Master Investor Masterclass

It was the Longevity Forum’s Longevity Week this week and this Science Panel, supported by Master Investor, benchmarks current Longevity science, probes the progress of senolytic therapies, explores the grey areas between supplements and medicine and explores which areas of the Longevity space get the investment nod from the world of science.

On this panel:

James Lawford Davies, Partner at Hill Dickinson, who specialises in life sciences and health tech regulation and litigation;

Polina Mamoshina, Chief Scientist and Chief Operating Officer at Deep Longevity, the Hong Kong-based company that uses deep learning and bioinformatics to identify biomarkers of ageing;

Reason, a pillar of the Longevity scene, Co-founder at Repair Biotechnologies and editor of;

First Longevity

Eric Verdin, CEO & President at Buck Institute for Research on Aging in San Francisco.

Phil Newman, CEO and founder First Longevity and Editor-in-Chief Longevity.Technology

The Longevity Week, 9-13 November 2020, is an initiative of The Longevity Forum. It brings together a diverse group of strategic partners of the Forum, supporters and participants whose goals are aligned with the mission of the Forum – to achieve longer, healthier and more fulfilled lives for as many people as possible. Our Investment Panel interview will be coming up on our website soon – stay tuned!

Check-out our weekly blog on Master Investor.

First Longevity
Phil Newman
Editor-in-Chief Phil is Editor-in-Chief Longevity.Technology and founder of Crowd Longevity a digital investment platform for international investors and Longevity start-ups launching in 2020.

In his career, Phil has held c-level management positions; applying his marketing and business development expertise into these tech sectors: Longevity; IoT; AI; Medical Devices; Biopharma; 3D Manufacturing; Smartgrid and Sustainability.

Latest articles

Neurotech2020 – a clear head for neurotech, research and investment

Tomorrow's dreams today ... well, next week – it's Neurotech2020. Neurotech2020 – the digital congress for neurotechnology innovation and growth – is coming to (your...

Biotech Elevian announces $15m equity financing

The anti-aging company looks to the clinic with Prime Movers Lab leading the round. Massachusets-based Elevian announced this week that it had closed $15 million equity...

eGenesis advances xenotransplantation research

Reducing waiting lists and treating diabetes – eGenesis progresses xeno without the paradox. Recently we covered eGenesis' progress in its xenotransplantation research, as it attempts...

Review: WHOOP fitness tracker

We trialled this beautifully-understated fitness/sleep tracking device to see if it would make us whoop with joy or holler for something else.   GO LONG    GO...